NOONAN SYNDROME

NOONAN SYNDROME

Named after a pediatric cardiologist, Jaqueline Anne Noonan, who characterized this condition, a ratio of 1:1,000-2,500 babies born have Noonan Syndrome. Noonan Syndrome is a common genetic disorder that exists since birth, and that affects the baby’s health and physical appearance.

Noonan syndrome, as a genetic disorder, is not caused by an infection or contagious agents such as a virus or bacteria. This disorder is caused by changes (mutation) in one of four autosomal dominant genes in their genetic code, which causes the abnormalities.

As to date, four genes have been identified that will cause Noonan Syndrome once altered, namely:

  • PTPN11 – accounts for approximately 50% of babies affected
  • SOS1 – accounts for 20% of babies affected
  • RADF1 – accounts for 10 – 15% of babies affected
  • KRAS – accounts for 5% of babies affected

The cause for the remaining 10-15% of babies affected with the disorder is yet to be known.

The defective gene linked with the disorder can be either inherited from a parent or be a random new mutation. Approximately 50% of the babies with the disease have inherited the flawed gene from an affected parent. In contrast, some babies carry this defective gene due to an error that randomly occurs without any genetic predisposition.

SYMPTOMS

The signs and symptoms related to Noonan Syndrome differ significantly from individual to individual. The disorder could display as mild, moderate, or severe. Signs and symptoms may also vary depending on which gene has an error.

Common signs and symptoms include:

  • Short stature
  • Distinct facial appearance (droopy and expressionless)
  • Wide-set and droopy eyes
  • External ear abnormalities
  • Short, broad, and webbed neck
  • Unusual chest shape with wide-spaced and low nipples
  • Heart disease
  • Bleeding issues
  • Scoliosis
  • Problems with the color and texture of the skin
  • Curly, rough, or sparse hair

There is also a developmental delay of different degrees, but this is usually mild and about 25% of individuals who have Noonan Syndrome are intellectually disabled.

DIAGNOSIS

Diagnosing Noonan Syndrome is based on the individual’s clinical signs and symptoms. It can often be difficult due to the subtlety of some of the signs related to the disorder. There are cases where an individual isn’t diagnosed with the disease until the baby shows more apparent signs and symptoms.

Through molecular genetic testing, a doctor or specialist’s diagnosis can be confirmed. Prenatal genetic screening tests are available if you think the unborn baby is at risk due to family history.

The earlier the disorder is diagnosed, the initial treatment and prevention strategies can be implemented, which will lead to better outcomes for the affected individual.

The average age when individuals are diagnosed is nine years old.

 

TREATMENT

Since Noonan Syndrome is a genetic issue, there is no cure. Treatment goals include managing its related signs, symptoms, and complications. Thus, management of the disorder will be tailored to the case, which varies from individual to individual.

Outlook

Individuals who have Noonan Syndrome have three times higher mortality rates compared to the general population. Individuals can have an average life expectancy if heart problems are absent.

However, since signs and symptoms vary from individual to individual, the outlook differs accordingly. With early intervention and management of the signs and symptoms, most individuals with Noonan Syndrome can reach adulthood and can lead independent lives.

Related Articles

TETRALOGY OF FALLOT

Overview and FactsTypes and SymptomsDiagnosis & MedicationsOverview and Facts Tetralogy of Fallot is a congenital heart defect that affects the [...]

TRICHINOSIS

Overview and FactsTypes and SymptomsDiagnosis & MedicationsOverview and Facts Trichinosis, also known as trichinellosis, is a parasitic infection caused by [...]

TRIGEMINAL NEURALGIA

Overview and FactsTypes and SymptomsDiagnosis & MedicationsOverview and Facts Trigeminal neuralgia is a neurological condition characterized by severe facial pain. [...]